✦ LIBER ✦

The large-scale manufacturing of electronic and electrical components in space

✍ Scribed by Douglas R. Sparks

Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 461 KB
Volume: 15
Category: Article
ISSN: 0094-5765
DOI: 10.1016/0094-5765(87)90006-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The qualification of electronic componen

The qualification of electronic components for use in space

✍ R.A. Reid 📂 Article 📅 1969 🏛 Elsevier Science 🌐 English ⚖ 704 KB

The demand for energy in the large-scale

The demand for energy in the large-scale manufacturing sector of Pakistan

✍ Fakhre Mahmud; Salim Chishti 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Electron beam welding in the manufacture

Electron beam welding in the manufacture of electronic components : A. Sanderson, Electron. Compon., October (1967), p. 1135

📂 Article 📅 1968 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Solar magnetic fields and large-scale el

Solar magnetic fields and large-scale electric currents in the active regions

✍ S.I. Gopasyuk 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 936 KB

Mokken scaling and principal components

Mokken scaling and principal components analyses of the CORE-OM in a large clinical sample

✍ A. Bedford; R. Watson; J. Lyne; J. Tibbles; F. Davies; I. J. Deary 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract In a sample of 543 adult National Health Service (NHS) patients referred to a Psychological Therapies Service, the responses to the Clinical Outcomes in Routine Evaluation‐Outcome Measure (CORE‐OM) self‐report questionnaire were examined using conventional principal components analysis

Large-scale manufacturing of safe and ef

Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols

✍ Deborah Farson; Ryan McGuinness; Tom Dull; Kay Limoli; Richard Lazar; Sayeh Jala 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 1 views

Background The use of gene modi®ed T lymphocytes for immunotherapy in a cancer or AIDS clinical trial requires an ef®cient, safe ex vivo method for modi®cation of these cells at manufacturing scale. Since retroviruses have been shown to be a moderately effective means of stably integrating therapeut